Genetic Technologies Limited (NASDAQ:GENE) was the recipient of a large increase in short interest in January. As of January 12th, there was short interest totalling 907,362 shares, an increase of 67.9% from the December 29th total of 540,347 shares. Based on an average daily volume of 1,188,197 shares, the days-to-cover ratio is currently 0.8 days.
Shares of Genetic Technologies (NASDAQ:GENE) opened at $1.81 on Friday. Genetic Technologies has a 1 year low of $0.70 and a 1 year high of $2.05.
Genetic Technologies Company Profile
Genetic Technologies Limited is a molecular diagnostics company. The Company is engaged in the provision of molecular risk assessment for cancer. The Company offers predictive testing and assessment tools for physicians to manage women’s health. The Company’s lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer.
Receive News & Ratings for Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetic Technologies and related companies with MarketBeat.com's FREE daily email newsletter.